首页 > 最新文献

Scandinavian journal of respiratory diseases. Supplementum最新文献

英文 中文
Basic aspects of bronchial anatomy--and further knowledge of pulmonary neuro-anatomy. 支气管解剖学的基本方面——以及肺神经解剖学的进一步知识。
L Reid
{"title":"Basic aspects of bronchial anatomy--and further knowledge of pulmonary neuro-anatomy.","authors":"L Reid","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":21458,"journal":{"name":"Scandinavian journal of respiratory diseases. Supplementum","volume":"103 ","pages":"13-8"},"PeriodicalIF":0.0,"publicationDate":"1979-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"11499662","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The parasympathetic nervous system in airways disease. 气道疾病中的副交感神经系统。
J G Widdicombe
{"title":"The parasympathetic nervous system in airways disease.","authors":"J G Widdicombe","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":21458,"journal":{"name":"Scandinavian journal of respiratory diseases. Supplementum","volume":"103 ","pages":"38-43"},"PeriodicalIF":0.0,"publicationDate":"1979-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"11499665","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Chemistry and pharmacokinetics of ipratropium bromide. 异丙托溴铵的化学及药代动力学。
K L Rominger
{"title":"Chemistry and pharmacokinetics of ipratropium bromide.","authors":"K L Rominger","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":21458,"journal":{"name":"Scandinavian journal of respiratory diseases. Supplementum","volume":"103 ","pages":"116-29"},"PeriodicalIF":0.0,"publicationDate":"1979-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"11373908","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acute effects of ipratropium bromide (ITBR, Sch 1000, Atrovent): a review of previous studies. 异丙托溴铵(ITBR, Sch 1000, Atrovent)的急性效应:以往研究综述。
B G Simonsson
{"title":"Acute effects of ipratropium bromide (ITBR, Sch 1000, Atrovent): a review of previous studies.","authors":"B G Simonsson","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":21458,"journal":{"name":"Scandinavian journal of respiratory diseases. Supplementum","volume":"103 ","pages":"130-42"},"PeriodicalIF":0.0,"publicationDate":"1979-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"11373909","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical trials in asthma. 哮喘的临床试验。
N Svedmyr
{"title":"Clinical trials in asthma.","authors":"N Svedmyr","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":21458,"journal":{"name":"Scandinavian journal of respiratory diseases. Supplementum","volume":"103 ","pages":"65-8"},"PeriodicalIF":0.0,"publicationDate":"1979-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"11582384","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Some aspects on bronchial challenges for evaluation of anti-allergic drugs. 抗过敏药物评价中支气管挑战的几个方面。
O Löwhagen, N Lindholm
{"title":"Some aspects on bronchial challenges for evaluation of anti-allergic drugs.","authors":"O Löwhagen, N Lindholm","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":21458,"journal":{"name":"Scandinavian journal of respiratory diseases. Supplementum","volume":"103 ","pages":"73-6"},"PeriodicalIF":0.0,"publicationDate":"1979-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"11582385","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Quality of survival in bronchial carcinoma. 支气管癌患者的生存质量。
E Nõu
{"title":"Quality of survival in bronchial carcinoma.","authors":"E Nõu","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":21458,"journal":{"name":"Scandinavian journal of respiratory diseases. Supplementum","volume":"104 ","pages":"1-41"},"PeriodicalIF":0.0,"publicationDate":"1979-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"11502964","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Safety of Atrovent. Atrovent的安全性。
A Lichterfeld
{"title":"Safety of Atrovent.","authors":"A Lichterfeld","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":21458,"journal":{"name":"Scandinavian journal of respiratory diseases. Supplementum","volume":"103 ","pages":"143-7"},"PeriodicalIF":0.0,"publicationDate":"1979-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"11373910","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bronchial carcinoma. IV. A methodological evaluation of the vitagram index for measurement of quality of survival. 支气管癌。IV.衡量生存质量的维生素图指数的方法学评价。
E Nõu, G Eklund

The validity of the Carlens Vitagram Index was tested by using the result of therapy in 48 patients with bronchial carcinoma in advanced disease, 54 patients with localized disease and 34 deceased treated surgically. The Carlens Vitagram Index, which is additional and composed of six items, was correlated to a set of additive indexes including the same items but other item weights, which were chosen with non-controversial pre-specified restrictions. The lowest correlation achieved was an indicator of the lowest degree of consistency that could be attributed to the Carlens Index given. The definition of the index was operationalized so far that each item in the set of six items included in the index was regarded as valid, and it was also considered reasonable that only these six items should be included; that each item had a weight; that the index was obtained as a product (weight x item value) sum and that the pre-specified conditions were accepted. By using restrictive conditions the lowest correlation between the index giving the lowest correlation and the Carlens Index for the 48 patients with localized disease was 0.98, for the 54 patients with localized disease 0.91 and for the surgically treated ones 0.83. In addition to the total index, the average index per month was also studied and the corresponding correlations were 0.96, 0.86 and 0.81 respectively. The Carlens Index and its application per month was found to have good validity for inoperable patients and acceptable validity for surgically treated patients. The Carlens Index was shown to be robust and there is reason to believe that it lies close to the optimal index.

通过48例晚期支气管癌患者、54例局部病变患者和34例手术死亡患者的治疗结果,验证了Carlens维生素agram指数的有效性。Carlens Vitagram指数是附加的,由六个项目组成,与一组附加指标相关,这些附加指标包括相同的项目,但其他项目的权重,这些指标的选择没有争议,预先规定了限制。获得的最低相关性是最低程度一致性的一个指标,可归因于给定的卡伦斯指数。索引的定义被操作到目前为止,在索引中包含的六个项目集合中的每个项目都被认为是有效的,并且也被认为是合理的,只有这六个项目应该被包括在内;每件物品都有重量;该指标以乘积(权重x项目值)和的形式得到,并且接受预先规定的条件。在限制性条件下,48例局限性疾病患者的最低相关性指数与Carlens指数的相关性为0.98,54例局限性疾病患者的最低相关性指数为0.91,手术治疗的最低相关性指数为0.83。除总指数外,还研究了月平均指数,相关系数分别为0.96、0.86和0.81。Carlens指数及其每月应用对不能手术患者有良好的效度,对手术患者有可接受的效度。Carlens指数被证明是稳健的,有理由相信它接近于最优指数。
{"title":"Bronchial carcinoma. IV. A methodological evaluation of the vitagram index for measurement of quality of survival.","authors":"E Nõu,&nbsp;G Eklund","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The validity of the Carlens Vitagram Index was tested by using the result of therapy in 48 patients with bronchial carcinoma in advanced disease, 54 patients with localized disease and 34 deceased treated surgically. The Carlens Vitagram Index, which is additional and composed of six items, was correlated to a set of additive indexes including the same items but other item weights, which were chosen with non-controversial pre-specified restrictions. The lowest correlation achieved was an indicator of the lowest degree of consistency that could be attributed to the Carlens Index given. The definition of the index was operationalized so far that each item in the set of six items included in the index was regarded as valid, and it was also considered reasonable that only these six items should be included; that each item had a weight; that the index was obtained as a product (weight x item value) sum and that the pre-specified conditions were accepted. By using restrictive conditions the lowest correlation between the index giving the lowest correlation and the Carlens Index for the 48 patients with localized disease was 0.98, for the 54 patients with localized disease 0.91 and for the surgically treated ones 0.83. In addition to the total index, the average index per month was also studied and the corresponding correlations were 0.96, 0.86 and 0.81 respectively. The Carlens Index and its application per month was found to have good validity for inoperable patients and acceptable validity for surgically treated patients. The Carlens Index was shown to be robust and there is reason to believe that it lies close to the optimal index.</p>","PeriodicalId":21458,"journal":{"name":"Scandinavian journal of respiratory diseases. Supplementum","volume":"104 ","pages":"131-71"},"PeriodicalIF":0.0,"publicationDate":"1979-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"11502965","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bronchial carcinoma. VI. Some aspects of the therapy of inoperable patients. 支气管癌。六、不能手术患者治疗的一些方面。
E Nõu

In small cell anaplastic carcinoma with localized disease the median survival for radiotherapy, single drug chemotherapy or operation was 10.1 months. The median survival for radiotherapy or single drug chemotherapy for small cell anaplastic carcinoma with extensive disease was 2.8 months and for untreated controls 0.5 months. The difference in the quality of survival was moderate, 2.0 vitagram points per month. Untreated epidermoid carcinoma patients with localized disease had a median survival of 11.4 months, which is the level reached by most non-surgical therapeutic regimes today.

局部病变的小细胞间变性癌,放疗、单药化疗或手术的中位生存期为10.1个月。伴有广泛病变的小细胞间变性癌,放疗或单药化疗的中位生存期为2.8个月,未治疗的对照组为0.5个月。生存质量的差异是中等的,每月2.0维格拉姆点。伴有局限性疾病的表皮样癌患者未经治疗的中位生存期为11.4个月,这是目前大多数非手术治疗方案所达到的水平。
{"title":"Bronchial carcinoma. VI. Some aspects of the therapy of inoperable patients.","authors":"E Nõu","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>In small cell anaplastic carcinoma with localized disease the median survival for radiotherapy, single drug chemotherapy or operation was 10.1 months. The median survival for radiotherapy or single drug chemotherapy for small cell anaplastic carcinoma with extensive disease was 2.8 months and for untreated controls 0.5 months. The difference in the quality of survival was moderate, 2.0 vitagram points per month. Untreated epidermoid carcinoma patients with localized disease had a median survival of 11.4 months, which is the level reached by most non-surgical therapeutic regimes today.</p>","PeriodicalId":21458,"journal":{"name":"Scandinavian journal of respiratory diseases. Supplementum","volume":"104 ","pages":"209-26"},"PeriodicalIF":0.0,"publicationDate":"1979-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"11502967","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Scandinavian journal of respiratory diseases. Supplementum
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1